Comorbidity profiling identifies potential subtype of elderly patients with nasopharyngeal carcinoma

Author:

Li Ying1,Pan Yuhui1,Huang Zongwei1,Wu Lishui1,Wu Wenxi1,Xu Siqi1,Chen Zihan1,Chen Xin1,Lu Jun1,Qiu Sufang123

Affiliation:

1. Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital , Fujian , People’s Republic of China

2. Fujian Key Laboratory of Translational Cancer Medicine , Fujian , People’s Republic of China

3. Fujian Provincial Key Laboratory of Tumor Biotherapy , Fujian , People’s Republic of China

Abstract

Abstract Background Few studies have assessed the comprehensive associations among comorbid diseases in elderly patients with nasopharyngeal carcinoma (NPC). This study sought to identify potential comorbidity patterns and explore the relationship of comorbidity patterns with the mortality risk in elderly patients with NPC. Methods A total of 452 elderly patients with NPC were enrolled in the study. The network analysis and latent class analysis were applied to mine comorbidity patterns. Propensity score matching was used for adjusting confounders. A restricted cubic spline model was used to analyze the nonlinear association between age and the risk of all-cause mortality. Results We identified 2 comorbidity patterns, metabolic disease-related comorbidity (MDRC) and organ disease-related comorbidity (ODRC) in elderly patients with NPC. Patients in MDRC showed a significantly higher risk of all-cause mortality (71.41% vs 87.97%, HR 1.819 [95% CI, 1.106-2.994], P = .031) and locoregional relapse (68.73% vs 80.88%, HR 1.689 [95% CI, 1.055-2.704], P = .042). Moreover, in patients with MDRC pattern, we observed an intriguing inverted S-shaped relationship between age and all-cause mortality among patients aged 68 years and older. The risk of mortality up perpetually with age increasing in ODRC group, specifically within the age range of 68-77 years (HR 4.371, 1.958-9.757). Conclusion Our study shed light on the potential comorbidity patterns in elderly patients with NPC, thereby providing valuable insights into the development of comprehensive health management strategies for this specific population.

Funder

Science and Technology Program of Fujian Province, China

Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy

Joint Funds for the innovation of science and Technology, Fujian Province

Natural Science Foundation of China

Major Research Projects for Young and Middle-aged Researchers of Fujian Provincial Health Commission

Science and Technology Pilot Program of Fujian Province, China

Wu Jieping Medical Foundation

Joint Funds for the Innovation of Science and Technology, Fujian province

Innovative Medicine Subject of Fujian Provincial Health Commission, China

High-level Talent Training Program of Fujian Cancer Hospital

Publisher

Oxford University Press (OUP)

Reference50 articles.

1. Population ageing in China: crisis or opportunity;The Lancet;Lancet,2022

2. Facing up to the global challenges of ageing;Partridge,2018

3. How comorbidities shape cancer biology and survival;Panigrahi,2021

4. The impact of comorbidity on cancer survival: a review;Søgaard,2013

5. Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms;Renzi,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3